Back to Journals » OncoTargets and Therapy » Volume 7 » Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia
Please verify you are not a robot.
Back to Journals » OncoTargets and Therapy » Volume 7 » Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia
Please verify you are not a robot.